Literature DB >> 3030937

Inhibition of human natural killer cell activity by Pseudomonas aeruginosa alkaline protease and elastase.

B K Pedersen, A Kharazmi.   

Abstract

The present study was designed to examine the effect of Pseudomonas aeruginosa alkaline protease (AP) and elastase (Ela) on human natural killer (NK) cell activity in vitro. AP and Ela were found to inhibit NK cell function. Addition of alpha interferon and interleukin-2 did not abolish this inhibition of NK cell activity. Adhesion of effector to target cells was studied in a single-cell agarose assay of monocyte-depleted NK-cell-enriched cell populations. AP and Ela were shown to inhibit effector/target cell conjugate formation. Furthermore, AP and Ela inhibited the binding of the monoclonal antibody Leu-11, which reacts with the Fc receptor of NK cells. The inhibition of NK cell binding to the target cell by P. aeruginosa proteases is most likely due to proteolytic cleavage of the surface receptors involved in the binding of the effector cell to the target cell.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3030937      PMCID: PMC260449          DOI: 10.1128/iai.55.4.986-989.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Large-scale production of human leukocyte interferon containing 10(8) units per ml.

Authors:  K Cantell; S Hirvonen
Journal:  J Gen Virol       Date:  1978-06       Impact factor: 3.891

2.  The invasion of burned skin by Pseudomonas aeruginosa.

Authors:  S A Carney; R E Dyster; R J Jones
Journal:  Br J Dermatol       Date:  1973-06       Impact factor: 9.302

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Mechanism of cell-mediated cytotoxicity at the single cell level. II. Evidence for first-order kinetics of T cell-mediated cytolysis and for heterogeneity of lytic rate.

Authors:  E A Grimm; J A Thoma; B Bonavida
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

5.  Analysis by a single cell cytotoxicity assay of natural killer (NK) cells frequencies among human large granular lymphocytes and of the effects of interferon on their activity.

Authors:  T Timonen; J R Ortaldo; R B Herberman
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

6.  Isolation of human NK cells by density gradient centrifugation.

Authors:  T Timonen; E Saksela
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

7.  Effect of Pseudomonas aeruginosa proteases on human leukocyte phagocytosis and bactericidal activity.

Authors:  A Kharazmi; H O Eriksen; G Döring; W Goldstein; N Høiby
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1986-10

8.  Interaction of pseudomonas exoproducts with phagocytic cells.

Authors:  B Weber; M M Nickol; K S Jagger; C B Saelinger
Journal:  Can J Microbiol       Date:  1982-06       Impact factor: 2.419

9.  Protease phenotypes of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.

Authors:  K S Jagger; D R Bahner; R L Warren
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

10.  Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection.

Authors:  L L Blackwood; R M Stone; B H Iglewski; J E Pennington
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.609

View more
  20 in total

Review 1.  Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?

Authors:  M Berger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

2.  Inhibitory and stimulatory effects of Pseudomonas aeruginosa pyocyanine on human T and B lymphocytes and human monocytes.

Authors:  A J Ulmer; J Pryjma; Z Tarnok; M Ernst; H D Flad
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

3.  The immune system and serum glutamine during a triathlon.

Authors:  T Rohde; D A MacLean; A Hartkopp; B K Pedersen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

Review 4.  Recent developments for Pseudomonas vaccines.

Authors:  Anurag Sharma; Anja Krause; Stefan Worgall
Journal:  Hum Vaccin       Date:  2011-10-01

5.  Inhibition of human natural killer cell activity by Legionella pneumophila protease.

Authors:  C Rechnitzer; M Diamant; B K Pedersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-11       Impact factor: 3.267

6.  Structural gene and complete amino acid sequence of Pseudomonas aeruginosa IFO 3455 elastase.

Authors:  J Fukushima; S Yamamoto; K Morihara; Y Atsumi; H Takeuchi; S Kawamoto; K Okuda
Journal:  J Bacteriol       Date:  1989-03       Impact factor: 3.490

7.  Recurrent infections and chronic colonization by an Escherichia coli clone in the respiratory tract of a patient with severe cystic bronchiectasis.

Authors:  J Y Wang; P R Hsueh; J T Wang; L N Lee; P C Yang; K T Luh
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

8.  Non-major histocompatibility complex-restricted cytotoxic activity of blood mononuclear cells stimulated with secreted mycobacterial proteins and other mycobacterial antigens.

Authors:  P Ravn; B K Pedersen
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

Review 9.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

10.  Pseudomonas aeruginosa eliminates natural killer cells via phagocytosis-induced apoptosis.

Authors:  Jin Woong Chung; Zheng-Hao Piao; Suk Ran Yoon; Mi Sun Kim; Mira Jeong; Suk Hyung Lee; Jeong Ki Min; Jae Wha Kim; You-Hee Cho; Jin Chul Kim; Jeong Keun Ahn; Kyoon Eon Kim; Inpyo Choi
Journal:  PLoS Pathog       Date:  2009-08-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.